HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

methyl 4-(adenin-9-yl)-2-hydroxybutanoate

suppresses antigen-induced specific immune responses, particularly Th1 responses, through inhibition of AdoHcy hydrolase and elevation of endogenous AdoHcy
Also Known As:
DZ2002
Networked: 8 relevant articles (4 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Tang, Wei: 6 articles (02/2021 - 05/2005)
2. Zuo, Jianping: 3 articles (02/2021 - 01/2019)
3. He, Shijun: 2 articles (02/2021 - 01/2019)
4. Lin, Zemin: 2 articles (02/2021 - 01/2019)
5. Liu, Yuting: 2 articles (02/2021 - 01/2019)
6. Li, Heng: 2 articles (12/2019 - 01/2018)
7. Qi, Qing: 2 articles (12/2019 - 01/2018)
8. Zuo, Jian-Ping: 2 articles (01/2018 - 05/2005)
9. Cao, Shiqi: 1 article (02/2021)
10. Chen, Li: 1 article (02/2021)

Related Diseases

1. Inflammation (Inflammations)
2. Glomerulonephritis
3. Systemic Scleroderma (Systemic Sclerosis)
4. Splenomegaly
5. Lupus Nephritis

Related Drugs and Biologics

1. Therapeutic Uses
2. Adenosylhomocysteinase
3. Hydrolases
4. Homocysteine
5. methyl 4-(adenin-9-yl)-2-hydroxybutanoate
6. Connective Tissue Growth Factor
7. Interleukin-12 Subunit p40
8. Interleukin-17 (Interleukin 17)
9. Chemokine CCL2 (Monocyte Chemoattractant Protein 1)
10. Interleukin-10 (Interleukin 10)

Related Therapies and Procedures

1. Topical Administration